[构建中国血液学共同体]
[To construct Chinese hematology community].
作者信息
Huang X J, Xu Z L
机构信息
Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematological Diseases, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation for the Treatment of Hematology, Beijing 100044, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2024 Jun 14;45(6):521-524. doi: 10.3760/cma.j.cn121090-20240523-00186.
Abstract
The development of hematology in China has gradually begun since the 1950s. After several generations of hard work, it has grown into a young but vibrant discipline. The development of Chinese hematology has experienced rapid rise and steady growth, but there is still a gap with the international level of hematology development. Only by constructing a Chinese community of hematology and forming a joint force to promote the development of hematology can we better realize the Chinese Dream in the field of hematology.
摘要
中国血液学的发展自20世纪50年代起逐步开始。经过几代人的努力，它已成长为一门年轻但充满活力的学科。中国血液学的发展经历了快速崛起和稳步增长，但与国际血液学发展水平仍存在差距。只有构建中国血液学共同体，形成推动血液学发展的合力，才能更好地实现血液学领域的中国梦。
相似文献
1
[To construct Chinese hematology community].[构建中国血液学共同体]
Zhonghua Xue Ye Xue Za Zhi. 2024 Jun 14;45(6):521-524. doi: 10.3760/cma.j.cn121090-20240523-00186.
2
[Healthy China 2030 critical care medicine: challenges accepted--40-year-chronicle of critical care medicine in China].《“健康中国2030”重症医学：迎接挑战——中国重症医学40年历程》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jul;31(7):793-800. doi: 10.3760/cma.j.issn.2095-4352.2019.07.001.
3
Hematologic health services and practical characteristics: report of a nationwide survey among Chinese hematologists.血液学健康服务及实用特征：一项针对中国血液学家的全国性调查的报告。
BMC Health Serv Res. 2024 Mar 12;24(1):326. doi: 10.1186/s12913-024-10829-z.
4
Mutual benefit for foreign medical students and Chinese postgraduates: A mixed team-based learning method overcomes communication problems in hematology clerkship.外国医学生与中国研究生的互利共赢：一种基于混合团队的学习方法克服了血液学临床实习中的沟通问题。
Biochem Mol Biol Educ. 2017 Mar 4;45(2):93-96. doi: 10.1002/bmb.20997. Epub 2016 Nov 1.
5
Hematology research output from Chinese authors and other countries: a 10-year survey of the literature.中国作者与其他国家作者的血液学研究产出：一项为期10年的文献调查
J Hematol Oncol. 2015 Feb 6;8:8. doi: 10.1186/s13045-014-0103-3.
6
Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China.亚太地区血液肿瘤学实践：第六届国际血液系统恶性肿瘤会议（2015年中国北京，弥合差距）的亚太血液肿瘤学大会（APHCON）调查结果
Oncotarget. 2017 Jun 20;8(25):41620-41630. doi: 10.18632/oncotarget.15655.
7
Launching an International Community of Practice in Hematology/Oncology Medical Education.发起血液学/肿瘤医学教育国际实践社区。
Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e100046. doi: 10.1200/EDBK_100046.
8
[Benchmarking China's Top-Tier Medical Institutions Against Global Standards: A Quantitative Analysis of the Gap Using Internationally Recognized Metrics].[以全球标准对标中国顶级医疗机构：使用国际认可指标对差距进行定量分析]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Jan 20;56(1):166-174. doi: 10.12182/20250160302.
9
Brief history of the Asiatic International Society of Hematology: our roots of international cooperation with Asian countries.亚洲国际血液学学会简史：我们与亚洲国家国际合作的根源。
Int J Hematol. 2018 Dec;108(6):566-570. doi: 10.1007/s12185-018-2549-5. Epub 2018 Oct 12.
10
[Reduce the burden of disease, realize the health dream of Chinese].减轻疾病负担，实现中国人的健康梦想
Zhonghua Yu Fang Yi Xue Za Zhi. 2015 Apr;49(4):289-91.
本文引用的文献
1
CAR T-cell therapies in China: rapid evolution and a bright future.中国的嵌合抗原受体 T 细胞疗法：快速发展，前景光明。
Lancet Haematol. 2022 Dec;9(12):e930-e941. doi: 10.1016/S2352-3026(22)00291-5.
2
Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions.中国靶向治疗时代的造血干细胞移植：当前的进展、挑战和未来方向。
Lancet Haematol. 2022 Dec;9(12):e919-e929. doi: 10.1016/S2352-3026(22)00293-9.
3
Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial.奥雷巴替尼（HQP1351），一种对 T315I 突变慢性髓性白血病患者耐受良好且有效的酪氨酸激酶抑制剂：开放标签、多中心 1/2 期试验的结果。
J Hematol Oncol. 2022 Aug 18;15(1):113. doi: 10.1186/s13045-022-01334-z.
4
Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial.携带高活性帕多瓦因子 IX 的工程化、肝脏靶向腺相关病毒载体在接受预防性糖皮质激素治疗的乙型血友病患者中的安全性和活性：一项单中心、单臂、1 期、初步试验。
Lancet Haematol. 2022 Jul;9(7):e504-e513. doi: 10.1016/S2352-3026(22)00113-2. Epub 2022 May 19.
5
A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide.一种新型的 NPM1-RARG-NPM1 嵌合融合在急性髓系白血病中类似于急性早幼粒细胞白血病，但对全反式维甲酸和三氧化二砷耐药。
Br J Cancer. 2019 May;120(11):1023-1025. doi: 10.1038/s41416-019-0456-z. Epub 2019 Apr 18.
6
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.急性早幼粒细胞白血病的治疗：欧洲白血病网专家小组的最新建议。
Blood. 2019 Apr 11;133(15):1630-1643. doi: 10.1182/blood-2019-01-894980. Epub 2019 Feb 25.
7
Identification of novel recurrent CPSF6-RARG fusions in acute myeloid leukemia resembling acute promyelocytic leukemia.在类似急性早幼粒细胞白血病的急性髓系白血病中鉴定新的复发性CPSF6-RARG融合基因。
Blood. 2018 Apr 19;131(16):1870-1873. doi: 10.1182/blood-2017-11-818716. Epub 2018 Feb 27.
8
Identification of novel recurrent - fusions in acute promyelocytic leukemia lacking t(15;17)(q22;q12)/-.在缺乏t(15;17)(q22;q12)/-的急性早幼粒细胞白血病中鉴定新的复发性融合基因
Blood. 2018 Feb 22;131(8):935-939. doi: 10.1182/blood-2017-09-807370. Epub 2017 Dec 13.
9
The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation.血液与骨髓移植临床试验网络：解决造血细胞移植重要问题的有效基础设施。
Biol Blood Marrow Transplant. 2016 Oct;22(10):1747-1757. doi: 10.1016/j.bbmt.2016.07.003. Epub 2016 Jul 11.
10
Haploidentical transplantation: the search for the best donor.单倍体相合移植：寻找最佳供者
Blood. 2014 Aug 7;124(6):827-8. doi: 10.1182/blood-2014-06-582460.
Zotero 插件